Sei sulla pagina 1di 82

Adult Immunization in 

the Workplace:
IMMUNIZATION FACTS AND MYTHS

JOSEFINA PAMELA O. CARPIO, MD, DPCOM
Outline 
• Immunization basics
• Workplace vaccines included in IPOPHL 
Immunization Program 2019
• Other Vaccines for Adults
• Side Effects of Vaccines
• Facts and Myths
IMMUNIZATION BASICS
Our Immune System

SOURCE • https://airfreshener.club/quotes/works-system-immune-it-how-visual.html (accessed 14 April 2019)


Immunity

Passive 
(maternal)
Innate  Natural
Immunity Active 
Immunity (infection)
Adaptive 
Immunity Passive 
(antibody 
transfer)
Artificial
Active 
(immunization)

SOURCE • Med in Action. Your Immune System, Vaccines and Traveling. https://www.medinaction.com/your-immune-system-vaccines-and-traveling/ (accessed 14 April 2019)
Immunization
“Immunization is the process 
whereby a person is made immune or resistant
to an infectious disease, 
typically by the administration of a vaccine.”

SOURCE • World Health Organization. Immunization. https://www.who.int/topics/immunization/en/ (accessed 08 April 2019)


How Vaccines Work

SOURCE • European Patient’s Academy. Vaccines. https://www.eupati.eu/types-of-medicines/vaccines/ (accessed 14 April 2019)


SOURCE • Northern Rivers Vaccination Supporters. Can Vaccines Overwhelm the Immune System? https://nrvs.info/faqs/toomanytoosoon/ (accessed 14 April 2019)
Types of Immunization
Active Passive
• A form of the bacteria or  • Antibodies are administered
virus is administered  • Usually post – exposure
• Immune system develops  • Examples:
antibodies  – Rabies
• Usually pre‐exposure – Tetanus
Types of Vaccines
Live, Attenuated Inactivated
• Live, but rendered unable to  • Killed bacteria or virus
cause infection or disease • Examples: Whole cell 
• Examples: BCG, OPV,  Pertussis, IPV
Measles, Rotavirus

Sub‐Unit Toxoid
• Purified antigen • Inactivated toxin
• Example: Acellular • Example: Tetanus Toxoid
Pertussis, Hib, PCV13, HepB

SOURCE • World Health Organization. Vaccine Safety Basics Module 1. https://vaccine-safety-training.org/types-of-vaccine-overview.html (accessed 11 April 2019)
Routes of Vaccine Administration

SOURCE • World Health Organization. Vaccine Safety Basics. http://vaccine-safety-training.org/history-of-vaccine-development.html (accessed 16 April 2019)
History of Vaccines
Vaccination Buddhist monks drank snake venom
(Cowpox virus for Smallpox) China, 17th Century
Edward Jenner, England, 1790s

Variolation (nasal 
insufflation)
China, 10th to 16th
Century

Variolation (via skin?)


India, Before 10th to 18th Century

Variolation (“buying the small pox” or


“hitting the pox”)
Sudan, Africa, 10th to 19th Century
SOURCE • The Immunisation Advisory Centre. A Brief History of Vaccination. http://www.immune.org.nz/vaccines/vaccine-development/brief-history-vaccination (accessed 08 April 2019)
• Riedel, Stefan. Edward Jenner and the history of smallpox and vaccination. Proc (Bayl Univ Med Cent). 2005 Jan; 18(1): 21–25.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1200696/ (accessed 08 April 2019)
• Wikipedia. Variolation. https://en.wikipedia.org/wiki/Variolation (accessed 08 April 2019)
• Immunization Action Coalition. Vaccine Timeline. http://www.immunize.org/timeline/ (accessed 11 April 2019)
• Smithsonian Institute. Image from The Mysterious Origins of the Smallpox vaccine. https://www.smithsonianmag.com/science-nature/mysterious-origins-smallpox-vaccine-
180970069/
Vaccines Through the Ages

SOURCE • World Health Organization. Vaccine Safety Basics. http://vaccine-safety-training.org/history-of-vaccine-development.html (accessed 16 April 2019)
Phases of Vaccine Development

SOURCE • https://www.researchgate.net/figure/The-different-stages-of-vaccine-development_fig2_301917070 (accessed 20 April 2019)


(ADULT) VACCINES INCLUDED IN THE 
IPOPHL IMMUNIZATION PROGRAM
Influenza Vaccine

Fluarix (GSK)
Fluquadri (Sanofi)
Agrippal S1 (Seqirus)
Influenza (Flu, Trangkaso)

• Virus
Infectious Agent • Influenza virus types A and B

• Airborne
Mode of 
• Objects and surfaces contaminated with respiratory 
Transmission secretions

Clinical  • Fever, headache
Presentation /  • Respiratory symptoms
Signs and  • Muscle and joint pain
Symptoms • Weakness and easy fatigability

SOURCE • Republic of the Philippines, Department of Health. Philippine Health Advisories 2012.
https://www.doh.gov.ph/sites/default/files/publications/PhilippineHealthAdvisories2012.compressed.pdf (accessed 13 April 2019)
Influenza Vaccine

TYPE OF VACCINE SCHEDULE AND ROUTE
• Inactivated • Single dose, annually (February to 
• Trivalent or Quadrivalent June)
• Intramuscular

TARGET INDIVIDUALS CONTRAINDICATIONS
• ALL individuals • Severe allergic reaction to vaccine 
• Chronic Diseases: Asthma, COPD,  component (e.g. egg) or to prior 
CVD dose 
• Immunocompromised • Moderate to severe illness with or 
• At increased risk (Healthcare  without fever
workers, community – service  • Guillain Barre Syndrome within 6 
providers) months after previous dose

SOURCE • Philippine Foundation for Vaccination. Adult Immunization Schedule. http://www.philvaccine.org/vaccination-schedules/adult-immunization-schedule (accessed 13 April 2019)
Pneumococcal Vaccine

PCV 13: Prevnar (Pfizer)
PPSV 23: Pneumo 23 (Sanofi) 
Pneumovax (Merck)
Pneumococcal Infection
• Bacteria 
Infectious Agent • Strep. pneumoniae

Mode of  • Airborne 
Transmission • Objects contaminated with respiratory secretions

• Ear Infections
Clinical 
• Sinusitis 
Presentation / 
• Pneumonia 
Signs and  • Meningitis
Symptoms • Sepsis
SOURCE • Republic of the Philippines, Department of Health. Philippine Health Advisories 2012.
https://www.doh.gov.ph/sites/default/files/publications/PhilippineHealthAdvisories2012.compressed.pdf (accessed 13 April 2019)
Pneumococcal Conjugated Vaccine (PCV13) 
and Polysaccharide Vaccine (PPSV23)
SCHEDULE AND ROUTE
TYPE OF VACCINE • Single dose
• Inactivated • PCV13 (IM) first  – PPSV23 at 
• Contains 13 or 23 strains least 2 months after
• PPSV23 (IM/SC) first – PCV at 
least 1 year after
• PPSV23 booster after 5 years 
TARGET INDIVIDUALS from initial dose
• ALL individuals
• Chronic diseases
• Immunocompromised CONTRAINDICATIONS
• Residents of nursing / long‐term  • Severe allergic reaction to vaccine 
care facilities component (e.g. phenol or 
• Smokers thimerosal) or to prior dose 
• Individuals >/=50yo • Moderate to severe illness with or 
without fever

SOURCE • Philippine Foundation for Vaccination. Adult Immunization Schedule. http://www.philvaccine.org/vaccination-schedules/adult-immunization-schedule (accessed 13 April 2019)
Human Papillomavirus (HPV) 
Vaccine
Cervarix (GSK)
Gardasil (Merck)
HPV Infection
• Virus
Infectious Agent
• Human papillomavirus (HPV)

Mode of 
• Direct contact with skin lesions
Transmission

Clinical Presentation 
/ Signs and  • Warts
Symptoms

Complications • Cervical cancer

SOURCE • Republic of the Philippines, Department of Health. Philippine Health Advisories 2012.
https://www.doh.gov.ph/sites/default/files/publications/PhilippineHealthAdvisories2012.compressed.pdf (accessed 13 April 2019)
Genital Warts in HPV Infection

SOURCE New Health Advisor. Do Genital Warts Hurt? https://www.newhealthadvisor.com/do-genital-warts-hurt.html (accessed 15 April 2019)
HPV Vaccine

TYPE OF VACCINE SCHEDULE AND ROUTE
• Inactivated • 3 doses: 0, 1‐2, 6 months
• Quadrivalent or Nonavalent • Intramuscular

TARGET INDIVIDUALS CONTRAINDICATIONS
• Immunocompetent adults,  • Severe allergic reaction to 
ideally until the age of 26yo vaccine component or to prior 
• Quadrivalent – for females dose 
• Nonavalent – for males and  • Moderate to severe illness with 
females or without fever
• Pregnancy

SOURCE • Philippine Foundation for Vaccination. Adult Immunization Schedule. http://www.philvaccine.org/vaccination-schedules/adult-immunization-schedule (accessed 13 April 2019)
Hepatitis Vaccines

Hepatitis A: Havrix (GSK), Avaxim 160 (Sanofi)


Hepatitis B: Engerix – B (GSK), Euvax (Sanofi)
Hepatitis A and B: Twinrix Adult (GSK)
Hepatitis A

Infectious  • Virus 
Agent • Hepatitis A virus (HAV)

Mode of 
• Fecal – oral route
Transmission

Clinical 
Presentation /  • Flu‐like symptoms and abdominal pain
Signs and  • Jaundice, dark urine, chalk‐colored stool
Symptoms
SOURCE • Republic of the Philippines, Department of Health. Philippine Health Advisories 2012.
https://www.doh.gov.ph/sites/default/files/publications/PhilippineHealthAdvisories2012.compressed.pdf (accessed 13 April 2019)
Hepatitis B
• Virus
Infectious Agent
• Hepatitis B virus (HBV)

Mode of 
• Blood
Transmission

Clinical Presentation  • Flu‐like symptoms and abdominal pain
/ Signs and 
Symptoms • Jaundice, dark urine, chalk‐colored stool

• Chronic Hepatitis B
Complications
• Cirrhosis, Liver Cancer

SOURCE • Republic of the Philippines, Department of Health. Philippine Health Advisories 2012.
https://www.doh.gov.ph/sites/default/files/publications/PhilippineHealthAdvisories2012.compressed.pdf (accessed 13 April 2019)
Hepatitis A and B Vaccine
TYPE OF VACCINE SCHEDULE AND ROUTE
• Inactivated / Recombinant • HepA: 2 doses ‐ 0, 6 months
• Single antigen, or combined • HepB or combined: 3 doses ‐
0, 1, 6 months

TARGET INDIVIDUALS
• ALL individuals
• Healthcare workers, and 
others with occupational  CONTRAINDICATIONS
hazards • Severe allergic reaction to 
• Residents and workers of  vaccine component (e.g. 
institutions baker’s yeast) or to prior dose 
• Travelers • Moderate to severe illness 
• Contacts of infected persons with or without fever
• Sexually active  • Pregnancy is NOT a 
• Chronic liver disease contraindication
• PLHIV
• Frequent recipients of blood
SOURCE • Philippine Foundation for Vaccination. Adult Immunization Schedule. http://www.philvaccine.org/vaccination-schedules/adult-immunization-schedule (accessed 13 April 2019)
Typhoid Vaccine

Typherix (GSK)
herixTyphim VI (Sanofi)
Typhoid (Enteric Fever)

Infectious  • bacteria
Agent • Salmonella typhi

Mode of 
• Fecal – oral route
Transmission

Clinical 
• High fever and headache
Presentation / 
• Weakness, loss of appetite
Signs and  • Abdominal pain with diarrhea or constipation
Symptoms
SOURCE • Republic of the Philippines, Department of Health. Philippine Health Advisories 2012.
https://www.doh.gov.ph/sites/default/files/publications/PhilippineHealthAdvisories2012.compressed.pdf (accessed 13 April 2019)
Typhoid Vaccine

TYPE OF VACCINE SCHEDULE AND ROUTE
• Capsular polysaccharide • Single dose
• Booster every 2 years
• Intramuscular
TARGET INDIVIDUALS
CONTRAINDICATIONS
• Immunocompetent
individuals in areas with high  • Severe allergic reaction to 
incidence of typhoid fever vaccine component or to 
prior dose 
• Moderate to severe illness 
with or without fever

SOURCE • Philippine Foundation for Vaccination. Adult Immunization Schedule. http://www.philvaccine.org/vaccination-schedules/adult-immunization-schedule (accessed 13 April 2019)
OTHER VACCINES FOR ADULTS
Varicella Vaccine

Varilrix (GSK)
Varivax (Merck)
Zostavax (Merck)
Varicella (Chickenpox, Bulutong)
• Virus
Infectious Agent • Varicella zoster virus (VZV)

• Airborne
Mode of 
• Objects contaminated with respiratory secretions 
Transmission or fluid from blisters 

Clinical Presentation  • Flu‐like symptoms
/ Signs and  • Blisters or vesicles, entire body (Primary 
Symptoms infection) or localized (Zoster)
• Permanent pain, numbness, muscle twitching
• Visual disturbances
Complications • Decreased hearing
• Zoster 
SOURCE • Republic of the Philippines, Department of Health. Philippine Health Advisories 2012.
https://www.doh.gov.ph/sites/default/files/publications/PhilippineHealthAdvisories2012.compressed.pdf (accessed 13 April 2019)
Varicella Infection: Chickenpox

SOURCE The Asian Parent Singapore. Adult chickenpox strikes 97-year-old who dies from complications. https://sg.theasianparent.com/adult-chickenpox (accessed 15 April 2019)
Varicella Infection: Zoster / Shingles

SOURCE Medscape. https://reference.medscape.com/features/slideshow/herpes-zoster (accessed 15 April 2019)


Varicella Vaccine
SCHEDULE AND ROUTE
TYPE OF VACCINE • 2 doses: 0, 1‐2 months
• Post‐exposure prophylaxis: 1 
• Live attenuated dose within 72 hours of exposure
• Subcutaneous

CONTRAINDICATIONS
• Severe allergic reaction to 
TARGET INDIVIDUALS vaccine component (e.g. gelatin 
• Immunocompetent adults or neomycin) or to prior dose 
• Healthcare workers • Moderate to severe illness with 
or without fever
• Pregnancy
• Immunosuppressed state
• Recent recipient of blood product

SOURCE • Philippine Foundation for Vaccination. Adult Immunization Schedule. http://www.philvaccine.org/vaccination-schedules/adult-immunization-schedule (accessed 13 April 2019)
Measles, Mumps, Rubella (MMR) 
Vaccine
Priorix (GSK)
MMR II (Merck)
Trimovax (Sanofi)
Measles or Rubeola (Tigdas)
• Virus
Infectious Agent • Measles or Rubeola virus

Mode of 
• Airborne / respiratory secretions 
Transmission

Clinical Presentation  • Flu‐like symptoms
/ Signs and  • Red eyes
Symptoms • Reddish rash, generalized, more than 3 days

• Diarrhea and Dehydration
• Ear Infections
Complications • Pneumonia
• Encephalitis
• Blindness
SOURCE • Republic of the Philippines, Department of Health. Philippine Health Advisories 2012.
https://www.doh.gov.ph/sites/default/files/publications/PhilippineHealthAdvisories2012.compressed.pdf (accessed 13 April 2019)
Measles

SOURCE United Kingdom National Health Services. Measles. https://www.nhs.uk/conditions/measles/symptoms/ (accessed 16 April 2019)
Mumps (Beke)
• Virus
Infectious Agent
• Mumps Virus

Mode of 
• Airborne / respiratory secretions 
Transmission

Clinical Presentation  • Flu‐like symptoms
/ Signs and 
Symptoms • Inflammed salivary glands

Complications • Infertility (males only)

SOURCE • Republic of the Philippines, Department of Health. Philippine Health Advisories 2012.
https://www.doh.gov.ph/sites/default/files/publications/PhilippineHealthAdvisories2012.compressed.pdf (accessed 13 April 2019)
Mumps

SOURCE WebMD. Chickenpox, Mumps and Measles: Not Just for Kids. https://www.webmd.com/vaccines/ss/slideshow-conditions-children-adults (accessed 16 April 2019)
Rubella 
(German Measles, Tigdas Hangin)
• Virus
Infectious Agent • Rubella Virus

Mode of  • Airborne / respiratory secretions 
Transmission

Clinical Presentation  • Swollen lymph nodes
/ Signs and  • Flu‐like symptoms
Symptoms • Reddish rash, generalized (head to toe), 3 days or less 

• Miscarriage or Stillbirth
Complications • Congenital Rubella Syndrome (deafness, cataracts, 
heart defects, intellectual disabilities, low birth weight)

SOURCE • Republic of the Philippines, Department of Health. Philippine Health Advisories 2012.
https://www.doh.gov.ph/sites/default/files/publications/PhilippineHealthAdvisories2012.compressed.pdf (accessed 13 April 2019)
Congenital Rubella Syndrome
Blueberry muffin rash
Congenital cataract

SOURCE Makadia S, Shah H, Patel B, Bhuptani N. Gregg syndrome: With blueberry muffin rash and congenital cataract. Indian J Paediatr Dermatol 2016;17:229-31.
http://www.ijpd.in/text.asp?2016/17/3/229/179496 (accessed 16 April 2019)
MMR Vaccine
SCHEDULE AND ROUTE
TYPE OF VACCINE
• 1‐2 doses at least 28 days apart
• Live attenuated • Subcutaneous

CONTRAINDICATIONS
TARGET INDIVIDUALS
• Severe allergic reaction to 
• Incomplete vaccination for MMR  vaccine component (e.g. gelatin 
during childhood or neomycin) or to prior dose 
• No previous infection • Moderate to severe illness with 
• With high risk of infection  or without fever
(healthcare workers, travelers) • Immunocompromised
• Pregnancy ‐ Women should be 
advised not to get pregnant until 
3 months after vaccination

SOURCE • Philippine Foundation for Vaccination. Adult Immunization Schedule. http://www.philvaccine.org/vaccination-schedules/adult-immunization-schedule (accessed 13 April 2019)
Meningococcal Vaccine

Mencevax ACWY (GSK)
Menactra (Sanofi)
Meningococcal Infection

• Bacteria 
Infectious Agent • Nisseria meningitides 

• Airborne
Mode of 
• Other objects contaminated with respiratory droplets, 
Transmission including food and eating utensils

Clinical  • Fever and respiratory symptoms
• Pinpoint rash, progressing into bruises
Presentation /  • Gangrene
Signs and  • Unstable vital signs
Symptoms • Neurologic signs (if with Meningitis)
SOURCE • Republic of the Philippines, Department of Health. Philippine Health Advisories 2012.
https://www.doh.gov.ph/sites/default/files/publications/PhilippineHealthAdvisories2012.compressed.pdf (accessed 13 April 2019)
Meningococcemia

SOURCE McLaren Flint. Meningococcemia on the leg. http://mclarenhealthplan.org/flint/health-information/2242.aspx (accessed 16 April 2019)
Meningococcal Vaccine

TYPE OF VACCINE SCHEDULE AND ROUTE
• Single dose
• Polysaccharide
• High‐risk groups: 2 doses 2 
• Quadrivalent months apart, and every 5 years
• Subcutaneous

TARGET INDIVIDUALS CONTRAINDICATIONS
• Travelers to highly endemic areas  • Severe allergic reaction to 
vaccine component or to prior 
dose 
• Moderate to severe illness with 
or without fever

SOURCE • Philippine Foundation for Vaccination. Adult Immunization Schedule. http://www.philvaccine.org/vaccination-schedules/adult-immunization-schedule (accessed 13 April 2019)
Rabies Vaccine

Rabipur (GSK)
Verorab (Sanofi)
Rabies
Infectious  • Virus
Agent • Rabies virus

• Bite of infected animal
Mode of 
• Open wound contaminated with saliva of infected 
Transmission animal

Clinical  • Headache and fever
• Pain or numbness on bite area
Presentation /  • Delirium, paralysis, muscle spasm
Signs and  • Hydrophobia or aerophobia
Symptoms • 100% fatal
SOURCE • Republic of the Philippines, Department of Health. Philippine Health Advisories 2012.
https://www.doh.gov.ph/sites/default/files/publications/PhilippineHealthAdvisories2012.compressed.pdf (accessed 13 April 2019)
Rabies Vaccine
TYPE OF VACCINE SCHEDULE AND ROUTE
• Purified Vero cell (PVRV) • PRE‐EXPOSURE PROPHYLAXIS:
• Purified chick embryo cell (PCEC) • Intradermal: Day 0, 7, 21/28
• Intramuscular: Day 0, 7, 21/28
• POST‐EXPOSURE:
TARGET INDIVIDUALS • Intradermal 2 site: Days 0, 3, 7, 
• Healthcare workers directly  and 28
caring for rabies patients • Intramuscular: Days 0, 3, 7, 24, 
• Pet – owners and 28
• Animal handlers
• Animal bite victims
CONTRAINDICATIONS
Severe allergic reaction to 
vaccine component or to prior 
dose 

SOURCE • Philippine Foundation for Vaccination. Adult Immunization Schedule. http://www.philvaccine.org/vaccination-schedules/adult-immunization-schedule (accessed 13 April 2019)
Tetanus, Diphtheria, Pertussis 
Vaccine
Boostrix (GSK)
Adacel (Sanofi)
Tetanus
• Bacteria
Infectious Agent
• Clostridium tetani

Mode of  • Contamination of wounds
Transmission

Clinical Presentation  • Localized muscle rigidity
/ Signs and  • Trismus / lockjaw
Symptoms • Generalized muscle spasm

• Asphyxia
Complications • Fractures and dislocations

SOURCE • Hinfrey, Patrick et al. Tetanus. Medscape. https://emedicine.medscape.com/article/229594-overview (accessed 15 April 2019)
Tetanus
Sir Charles Bell’s portrait of a soldier dying of tetanus.

SOURCE • No Measles. Tetanus. https://www.nomeasles.com/tetanus/ (accessed 16 April 2019)


Diphtheria
• Bacteria
Infectious Agent • Corynebacterium diphtheria

Mode of  • Airborne (respiratory droplets) 
Transmission • Objects contaminated with respiratory secretions

• Fever, chills, malaise
• Throat pain, difficult / painful swallowing
Signs and  • Hoarseness
Symptoms • Graying membrane covering throat and tonsils
• Difficulty breathing

SOURCE • Republic of the Philippines, Department of Health. Philippine Health Advisories 2012.
https://www.doh.gov.ph/sites/default/files/publications/PhilippineHealthAdvisories2012.compressed.pdf (accessed 13 April 2019)
Tonsillitis and Diphtheria

SOURCE • Abas, Azura. Five Diphtheria Deaths in Malaysia So Far. New Straits Times. https://www.nst.com.my/news/2016/06/155591/five-diphtheria-deaths-malaysia-so-far (accessed
13 April 2019)
Pertussis (Whooping Cough)

Infectious  • Bacteria
Agent • Bordetella pertussis

Mode of  • Airborne / respiratory secretions
Transmission • Objects contaminated with respiratory secretions

• Cough persisting 2 or more weeks
Signs and 
• Coughing fits
Symptoms • Cough followed by vomiting

SOURCE • Republic of the Philippines, Department of Health. Philippine Health Advisories 2012.
https://www.doh.gov.ph/sites/default/files/publications/PhilippineHealthAdvisories2012.compressed.pdf (accessed 13 April 2019)
Tetanus, Diphtheria, 
and Pertussis Vaccine
TYPE OF VACCINE SCHEDULE AND ROUTE
• Inactivated • 3 doses: 2nd dose 4 – 8 
weeks after 1st dose, 3rd
dose 6 – 12 months after 
TARGET INDIVIDUALS 2nd dose
• last vaccination 10 years ago • 1 dose of the 3 should be 
• close contact to infants Tdap
• before pregnancy or 
immediately after delivery CONTRAINDICATIONS
• Healthcare workers
• Severe allergic reaction to 
vaccine component or to 
prior dose 
• Moderate to severe 
illness
SOURCE • Philippine Foundation for Vaccination. Adult Immunization Schedule. http://www.philvaccine.org/vaccination-schedules/adult-immunization-schedule (accessed 13 April 2019)
SIDE EFFECTS OF IMMUNIZATION
Common Side Effects of Vaccines
• injection site reactions (pain, swelling and 
redness)
• fever
• shivering / chills
• fatigue / extreme tiredness 
• headache
• muscle and joint pain

SOURCE • United Kingdome National Health Services. Vaccination. https://www.nhs.uk/conditions/vaccinations/reporting-side-effects/ (accessed 16 April 2019)
Relief of Side Effects
• Hydrate
• Cold compress 
• OTC pain reliever
• Move arm around

SOURCE • US Department of Health and Human Services. What to Expect – for Adults. https://www.vaccines.gov/getting/for_adults (accessed 16 April 2019)
Rare Side Effects of Vaccination
• Allergic reactions
• Severe allergic reaction Æ Anaphylaxis
• Guillain Barre Syndrome

SOURCE • United Kingdome National Health Services. Vaccination. https://www.nhs.uk/conditions/vaccinations/reporting-side-effects/ (accessed 16 April 2019)
Immunization

FACTS AND MYTHS
True or False?
False / Myth Facts
Better hygiene and  • Better hygiene protects people from 
sanitation will make  many infectious diseases.
diseases disappear – • Many infections can spread 
vaccines are not  regardless of how clean we are.
necessary • If we stop vaccination, diseases that 
have become uncommon (e.g. polio 
and measles) will quickly reappear.

SOURCE • World Health Organization. Questions and Answers on Immunization. https://www.who.int/vietnam/news/feature-stories/detail/questions-and-answers-on-immunization


(accessed 16 April 2019)
True or False?
False / Myth Facts
Vaccine‐preventable  • Infectious agents continue to 
diseases are almost  circulate in some parts of the world 
eradicated in my  and can cross geographical borders 
country, so there is no  and infect anyone who is not 
reason to be  protected. 
vaccinated.  • Example: Measles outbreaks 

SOURCE • World Health Organization. Questions and Answers on Immunization. https://www.who.int/vietnam/news/feature-stories/detail/questions-and-answers-on-immunization


(accessed 16 April 2019)
True or False?
False / Myth Facts
Vaccine‐preventable  • Illnesses such as measles, mumps and 
childhood illnesses  rubella are serious and can lead to 
severe complications (pneumonia, 
are just an  encephalitis, blindness, diarrhoea, ear 
unfortunate fact of  infections, congenital rubella syndrome, 
life.  and death) 
• Failure to vaccinate against these 
diseases leaves children unnecessarily 
vulnerable.
• All these diseases and suffering can be 
prevented with vaccines, and do not 
necessarily have to be “facts of life.”

SOURCE • World Health Organization. Questions and Answers on Immunization. https://www.who.int/vietnam/news/feature-stories/detail/questions-and-answers-on-immunization


(accessed 16 April 2019)
True or False?
True / Fact Facts
Giving a child more  • Giving several vaccines at the same time 
than one vaccine at a  has no adverse effect on a child’s 
time does not  immune system
increase the risk of  • Children are exposed to several hundred 
harmful side‐effects,  foreign substances that trigger an 
and will not overload  immune response every day. 
the child’s immune  • Key advantages of having several 
system. vaccines at once:
– Fewer clinic visits
– Fewer injections
– Better compliance to schedule

SOURCE • World Health Organization. Questions and Answers on Immunization. https://www.who.int/vietnam/news/feature-stories/detail/questions-and-answers-on-immunization


(accessed 16 April 2019)
True or False?
False / Myth Facts
Vaccines contain  • Thiomersal
mercury, which makes  – organic, mercury‐containing compound
vaccines dangerous.  – added in safe quanities to some 
vaccines as a preservative
– usually used in multi‐dose vials 
• No evidence suggesting thiomersal
amount in multi‐dose vials poses a 
health risk

SOURCE • World Health Organization. Questions and Answers on Immunization. https://www.who.int/vietnam/news/feature-stories/detail/questions-and-answers-on-immunization


(accessed 16 April 2019)
True or False?
True / Fact Facts
Vaccines do not cause  • 1998 ‐ study showed possible link 
autism.  between measles‐mumps‐rubella 
(MMR) vaccine and autism 
• Discovered to be seriously flawed, 
and paper has been retracted by the 
journal that published it

SOURCE • World Health Organization. Questions and Answers on Immunization. https://www.who.int/vietnam/news/feature-stories/detail/questions-and-answers-on-immunization


(accessed 16 April 2019)
True or False?
False / Myth Facts
Dengue vaccine  • Dengue infection may cause severe 
(Dengvaxia) causes  and fatal bleeding
bleeding, which may  • Autopsy studies of alleged deaths 
be severe and life‐ due to Dengvaxia, done by UPCM 
threatening. team of experts, showed that fatal 
hemorrhage was due to Dengue 
infection.

SOURCE • World Health Organization. Questions and Answers on Immunization. https://www.who.int/vietnam/news/feature-stories/detail/questions-and-answers-on-immunization


(accessed 16 April 2019)
SOURCE • Sio – Aguilar, Julieta. Highlights of the PGH DITF Findings and Recommendations. UPCM – PGH, UP Med Webinars. February 7, 2018.
SOURCE • Sio – Aguilar, Julieta. Highlights of the PGH DITF Findings and Recommendations. UPCM – PGH, UP Med Webinars. February 7, 2018.
SOURCE • Sio – Aguilar, Julieta. Highlights of the PGH DITF Findings and Recommendations. UPCM – PGH, UP Med Webinars. February 7, 2018.
SOURCE • Sio – Aguilar, Julieta. Highlights of the PGH DITF Findings and Recommendations. UPCM – PGH, UP Med Webinars. February 7, 2018.
SOURCE • Sio – Aguilar, Julieta. Highlights of the PGH DITF Findings and Recommendations. UPCM – PGH, UP Med Webinars. February 7, 2018.
SOURCE • Sio – Aguilar, Julieta. Highlights of the PGH DITF Findings and Recommendations. UPCM – PGH, UP Med Webinars. February 7, 2018.
SOURCE • Sio – Aguilar, Julieta. Highlights of the PGH DITF Findings and Recommendations. UPCM – PGH, UP Med Webinars. February 7, 2018.
SOURCE • Sio – Aguilar, Julieta. Highlights of the PGH DITF Findings and Recommendations. UPCM – PGH, UP Med Webinars. February 7, 2018.
Thank you for listening!

Potrebbero piacerti anche